Cornelia Englisch

Medical University of Vienna

Austria

Research Interests

Explore related searches

Professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (16)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (5)

Cihan Ay

Professor, MD

Medical University of Vienna

AUSTRIA

View details

Stephan Nopp

Medical University of Vienna

AUSTRIA

View details

Matthias Preusser

Medical University

AUSTRIA

View details

Simon Kraler

SWITZERLAND

View details

Arnold von Eckardstein

chairman of the institute/ professor

University of Zurich

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Cornelia Englisch

Research Interests

Explore related searches

Contact this professor

Articles (16)

Clonal Hematopoiesis and Cardiovascular Events in Patients with ESKD on Hemodialysis

Validation of risk assessment models for venous thromboembolism in patients with cancer receiving systemic therapies

Clonal Hematopoiesis and Thrombosis

Clonal hematopoiesis in patients with cancer and its association with risk of thrombosis and prognosis of disease

Growth Differentiation Factor-15 Predicts Major Bleeding in Cancer Patients

The Vienna CATScore for predicting cancer-associated venous thromboembolism: an external validation across multiple time points

Association of clonal haematopoiesis with recurrent venous thromboembolism: A case–control study

Risk assessment and prevention of cancer-associated venous thromboembolism in ambulatory patients with solid malignancies

Bleeding events in patients with cancer: incidence, risk factors, and impact on prognosis in a prospective cohort study

Early Change in C-Reactive Protein and Venous Thromboembolism in Patients Treated With Immune Checkpoint Inhibitors

Growth differentiation factor-15 and prediction of cancer-associated thrombosis and mortality: a prospective cohort study

Antithrombin Activity and Association with Risk of Thrombosis and Mortality in Patients with Cancer.

ABO blood group type and risk of venous thromboembolism in patients with cancer.

Risk assessment for recurrent venous thromboembolism in patients with cancer

Risk assessment models of cancer-associated thrombosis - Potentials and perspectives

Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer

Collaborators (5)

Cihan Ay

Stephan Nopp

Matthias Preusser

Simon Kraler

Arnold von Eckardstein

Make your next move.